Source: Proceedings of the American Association for Cancer Research. Conference titles: Annual Meeting American Association for Cancer Research. Unidade: FM
Subjects: RNA POLIMERASES, EXPRESSÃO GÊNICA, PROGNÓSTICO, NEOPLASIAS BUCAIS, RESUMOS
ABNT
PASINI, Fatima S et al. Ras-GTPase activating protein SH3 domain-binding protein 2 (G3BP2),tissue factor alternative splicing form (asHTF) and 3-hydroxy-3-methylglutaryl-coenzymeA reductase (HMGCR) as prognostic factors in oral. Proceedings of the American Association for Cancer Research. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 21 maio 2024. , 2007APA
Pasini, F. S., Maistro, S., Barbeta, L. P., Cadima, B. F., Mangone, F. R., Lehn, C. N., et al. (2007). Ras-GTPase activating protein SH3 domain-binding protein 2 (G3BP2),tissue factor alternative splicing form (asHTF) and 3-hydroxy-3-methylglutaryl-coenzymeA reductase (HMGCR) as prognostic factors in oral. Proceedings of the American Association for Cancer Research. Philadelphia: Faculdade de Medicina, Universidade de São Paulo.NLM
Pasini FS, Maistro S, Barbeta LP, Cadima BF, Mangone FR, Lehn CN, Walder F, Carvalho MB, Cantanoso MF, Brentani MM, Federico MHH. Ras-GTPase activating protein SH3 domain-binding protein 2 (G3BP2),tissue factor alternative splicing form (asHTF) and 3-hydroxy-3-methylglutaryl-coenzymeA reductase (HMGCR) as prognostic factors in oral. Proceedings of the American Association for Cancer Research. 2007 ;[citado 2024 maio 21 ]Vancouver
Pasini FS, Maistro S, Barbeta LP, Cadima BF, Mangone FR, Lehn CN, Walder F, Carvalho MB, Cantanoso MF, Brentani MM, Federico MHH. Ras-GTPase activating protein SH3 domain-binding protein 2 (G3BP2),tissue factor alternative splicing form (asHTF) and 3-hydroxy-3-methylglutaryl-coenzymeA reductase (HMGCR) as prognostic factors in oral. Proceedings of the American Association for Cancer Research. 2007 ;[citado 2024 maio 21 ]